309 related articles for article (PubMed ID: 25855880)
1. Fecal calprotectin use in inflammatory bowel disease and beyond: A mini-review.
Alibrahim B; Aljasser MI; Salh B
Can J Gastroenterol Hepatol; 2015 Apr; 29(3):157-63. PubMed ID: 25855880
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of calprotectin in irritable bowel syndrome and in inflammatory bowel disease.
Grad C; David L; Portincasa P; Dumitraşcu DL
Rom J Intern Med; 2012; 50(1):3-6. PubMed ID: 22788087
[TBL] [Abstract][Full Text] [Related]
3. [Faecal calprotectin is a useful biomarker for intestinal inflammation].
Theede K; Kiszka-Kanowitz M; Nordgaard-Lassen I; Nielsen AM
Ugeskr Laeger; 2014 Sep; 176(37):. PubMed ID: 25294035
[TBL] [Abstract][Full Text] [Related]
4. Utility of fecal calprotectin in differentiating active inflammatory bowel disease from coexistent irritable bowel syndrome.
Sprakes MB; Hamlin PJ; Ford AC
Am J Gastroenterol; 2011 Jan; 106(1):166; author reply 166-7. PubMed ID: 21212757
[No Abstract] [Full Text] [Related]
5. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
[TBL] [Abstract][Full Text] [Related]
6. Fecal calprotectin in inflammatory bowel diseases: update and perspectives.
Manceau H; Chicha-Cattoir V; Puy H; Peoc'h K
Clin Chem Lab Med; 2017 Mar; 55(4):474-483. PubMed ID: 27658156
[TBL] [Abstract][Full Text] [Related]
7. [Measurement of calprotectin in faeces].
Jahnsen J; Røseth AG; Aadland E
Tidsskr Nor Laegeforen; 2009 Apr; 129(8):743-5. PubMed ID: 19373299
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome.
Otten CM; Kok L; Witteman BJ; Baumgarten R; Kampman E; Moons KG; de Wit NJ
Clin Chem Lab Med; 2008; 46(9):1275-80. PubMed ID: 18597588
[TBL] [Abstract][Full Text] [Related]
9. Analytical Performance and Clinicopathologic Correlation of Four Fecal Calprotectin Methods.
Pelkmans LPJ; de Groot MJM; Curvers J
Am J Clin Pathol; 2019 Aug; 152(3):392-398. PubMed ID: 31152542
[TBL] [Abstract][Full Text] [Related]
10. A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease.
Gacesa R; Vich Vila A; Collij V; Mujagic Z; Kurilshikov A; Voskuil MD; Festen EAM; Wijmenga C; Jonkers DMAE; Dijkstra G; Fu J; Zhernakova A; Imhann F; Weersma RK
Gut Microbes; 2021; 13(1):1943288. PubMed ID: 34313538
[TBL] [Abstract][Full Text] [Related]
11. Calprotectin in Daily Practice: Where Do We Stand in 2017?
D'Angelo F; Felley C; Frossard JL
Digestion; 2017; 95(4):293-301. PubMed ID: 28511188
[TBL] [Abstract][Full Text] [Related]
12. [The role of fecal calprotectin in the diagnosis and treatment of gastrointestinal diseases].
Iliás Á; Rózsa FP; Gönczi L; Lovász BD; Kürti Z; Lakatos PL
Orv Hetil; 2019 Mar; 160(9):322-328. PubMed ID: 30798622
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic power of fecal calprotectin in inflammatory and functional intestinal disorders.
Agilli M; Aydin FN; Gulcan Kurt Y; Cayci T
Scand J Gastroenterol; 2015 Mar; 50(3):376-7. PubMed ID: 25582762
[No Abstract] [Full Text] [Related]
14. Interest of fecal calprotectine dosage in inflammatory bowel diseases, state of the art and perspectives.
Chaabouni T; Manceau H; Peoc'h K
Ann Biol Clin (Paris); 2016 Aug; 74(4):385-94. PubMed ID: 27492691
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS.
Menees SB; Powell C; Kurlander J; Goel A; Chey WD
Am J Gastroenterol; 2015 Mar; 110(3):444-54. PubMed ID: 25732419
[TBL] [Abstract][Full Text] [Related]
16. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease.
Konikoff MR; Denson LA
Inflamm Bowel Dis; 2006 Jun; 12(6):524-34. PubMed ID: 16775498
[TBL] [Abstract][Full Text] [Related]
17. Faecal calprotectin: the case for a novel non-invasive way of assessing intestinal inflammation.
Gearry R; Barclay M; Florkowski C; George P; Walmsley T
N Z Med J; 2005 May; 118(1214):U1444. PubMed ID: 15886739
[No Abstract] [Full Text] [Related]
18. [Fecal calprotectin in differential diagnosis of irritable bowel syndrome].
Li XG; Lu YM; Gu F; Yang XL
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):310-3. PubMed ID: 16778979
[TBL] [Abstract][Full Text] [Related]
19. Faecal calprotectin in the diagnosis of inflammatory bowel disease.
Burri E; Beglinger C
Biochem Med (Zagreb); 2011; 21(3):245-53. PubMed ID: 22420238
[TBL] [Abstract][Full Text] [Related]
20. Calprotectin testing in the community.
Wassell J
Ann Clin Biochem; 2011 Jan; 48(Pt 1):1-2. PubMed ID: 21273635
[No Abstract] [Full Text] [Related]
[Next] [New Search]